IP Verse

Retroviral Transduction Using Poloxamers

Patent No. EP2820138 (titled "Retroviral Transduction Using Poloxamers") was filed by Helmholtz Zentrum Mnchen Deutsches Forschungszentrum FR Gesundheit UND Umwelt on Feb 28, 2013. The application was issued on Oct 28, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KONIG SZYNKA TILMANN VON RENESSEJul 27, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSEJul 27, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2820138

HELMHOLTZ ZENTRUM MNCHEN DEUTSCHES FORSCHUNGSZENTRUM FR GESUNDHEIT UND UMWELT
Application Number
EP13706283A
Filing Date
Feb 28, 2013
Status
Opposition Rejected
Feb 7, 2025
Publication Date
Oct 28, 2020
External Links
Slate, Register , Google Patents